ELIXINOL WELLNESS LIMITED (EXL)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
EXL - ELIXINOL WELLNESS LIMITED
FNArena Sector : Health & Nutrition
Year End: December
GICS Industry Group : Household & Personal Products
Debt/EBITDA: -0.22
Index:
| LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
|---|---|---|---|
|
$0.014
30 Nov |
OPEN $0.01 |
HIGH $0.01 |
567,807 LOW $0.01 |
0.001| OTHER COMPANIES IN THE SAME SECTOR | |||
| CLV . EBO . MCP . SIG . | |||
FNARENA'S MARKET CONSENSUS FORECASTS
- No Record -
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
| Title | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EPS Basic | xxx | xxx | xxx | xxx | -3.3 |
| DPS All | xxx | xxx | xxx | xxx | 0.0 |
| Sales/Revenue | xxx | xxx | xxx | xxx | 7.1 M |
| Book Value Per Share | xxx | xxx | xxx | xxx | 2.9 |
| Net Operating Cash Flow | xxx | xxx | xxx | xxx | -8.2 M |
| Net Profit Margin | xxx | xxx | xxx | xxx | -149.84 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
| Title | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Return on Capital Employed | xxx | xxx | xxx | xxx | -74.88 % |
| Return on Invested Capital | xxx | xxx | xxx | xxx | -69.26 % |
| Return on Assets | xxx | xxx | xxx | xxx | -54.47 % |
| Return on Equity | xxx | xxx | xxx | xxx | -74.88 % |
| Return on Total Capital | xxx | xxx | xxx | xxx | -61.14 % |
| Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | -8.2 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
| Title | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Short-Term Debt | xxx | xxx | xxx | xxx | 1 M |
| Long Term Debt | xxx | xxx | xxx | xxx | 1 M |
| Total Debt | xxx | xxx | xxx | xxx | 2 M |
| Goodwill - Gross | xxx | xxx | xxx | xxx | - |
| Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | 3 M |
| Price To Book Value | xxx | xxx | xxx | xxx | 0.72 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
| Title | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Capex | xxx | xxx | xxx | xxx | 0.0 M |
| Capex % of Sales | xxx | xxx | xxx | xxx | 0.17 % |
| Cost of Goods Sold | xxx | xxx | xxx | xxx | 10 M |
| Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | 7 M |
| Research & Development | xxx | xxx | xxx | xxx | - |
| Investments - Total | xxx | xxx | xxx | xxx | 3 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
EXL STOCK CHART
FNArena News on EXL
| 1 |
Rudi’s View: All Eyes On November 3Sep 24 2020 - Rudi's View |
| 2 |
Australian Broker Call *Extra* Edition – July 1, 2020Jul 01 2020 - Daily Market Reports |
| 3 |
Australian Broker Call *Extra* Edition – Apr 06, 2020Apr 06 2020 - Daily Market Reports |
| 4 |
Australian Broker Call *Extra* Edition – Feb 17, 2020Feb 17 2020 - Daily Market Reports |
| 5 |
Australian Broker Call *Extra* Edition – Jun 12, 2019Jun 12 2019 - Daily Market Reports |
Latest Health & Nutrition News
| 1 |
Sigma Healthcare Promises Higher MarginsOct 03 2023 - Small Caps |
| 2 |
Sigma’s Win Not Neccessarily Ebos’ LossJun 14 2023 - Small Caps |
| 3 |
Sigma Healthcare: Brokers WaryMar 31 2022 - Australia |
| 4 |
Health & Wellness Boom On The ASXApr 29 2021 - Weekly Reports |
| 5 |
M&A Now On Sigma Healthcare’s AgendaMar 24 2021 - Australia |
| 6 |
McPherson’s Expands Into Herbal HealthNov 04 2020 - Small Caps |
| 7 |
Nine Ignored Companies Now Worth A LookSep 23 2020 - FYI |
| 8 |
Next Week At A Glance – 14-18 Sep 2020Sep 11 2020 - Weekly Reports |
| 9 |
Sigma Farewells API, Heralds New ContractDec 17 2019 - Australia |
| 10 |
Blackmores: Hopes Pinned On RestructuringNov 01 2019 - Australia |
